Burnaby, BC, Canada - January 29, 2010, Burnaby, BC, Canada - Tekmira Pharmaceuticals Corporation, a biotechnology company, announced the appointment of Daniel Kisner, Kenneth Galbraith and Frank Karbe to its board. Mr. Kisner will become chairman of the board.
Article continues below
Dr. Kisner is currently a Venture Partner at Aberdare Ventures, a leading US healthcare investor. Dr. Kisner is a physician and former tenured professor with significant industry experience and a successful track record leading development-stage biotechnology companies. Dr. Kisner's previous experience includes building companies as CEO of Caliper Technologies, a leader in microfluidic lab-on-a-chip technology, and as COO of Isis Pharmaceuticals, Inc., a developer of nucleic acid therapeutics.
Dr. Kisner also worked as a drug development executive with Abbott Laboratories and SmithKline Beckman Pharmaceuticals. Dr. Kisner is certified by the American Board of Internal Medicine in Internal Medicine and Medical Oncology.
Mr. Galbraith is currently a General Partner at Ventures West, the largest private venture capital firm in Canada. Mr. Galbraith has mora than 20 years experience as an executive, director and investor of leading biotechnology companies such as QLT, Inc., AnorMED, Cardiome Pharma and Angiotech Pharmaceuticals.
In 2006, Mr. Galbraith served as the Chairman and Interim CEO of AnorMED, the developer of the approved stem cell mobililzer drug Mozibil, until its sale to Genzyme Corp. in a cash transaction worth almost US$600 million. Previously, Mr. Galbraith was Executive Vice President and CFO with QLT Inc., a global biopharmaceutical company. Mr. Galbraith is a chartered accountant.
Mr. Karbe is currently the Executive Vice President and CFO of Exelixis, Inc., a biotechnology company. Prior to joining Exelixis in 2004, Mr. Karbe worked with Goldman Sachs & Co. specializing in corporate finance and mergers and acquisitions in the biotechnology sector. Previously, Mr. Karbe was in the finance department with The Royal Dutch/Shell Group in Europe. Mr. Karbe has a graduate degree in business administration. ■